Hendrik Schulze-Koops

InstitutionDeutsche Gesellschaft für Rheumatologie e.?V.
AddressGermany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 25 Covid-19 publications, with a maximum of 4 publications in June 2020
    All Publications
    Bar chart showing 205 publications over 28 distinct years, with a maximum of 18 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hasseli R, Pfeil A, Hoyer BF, Lorenz HM, Regierer AC, Richter JG, Schmeiser T, Strangfeld A, Voll RE, Krause A, Schulze-Koops H, Müller-Ladner U, Specker C. [German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]. Z Rheumatol. 2021 Sep; 80(7):641-646. PMID: 34196793.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    2. Sparks JA, Wallace ZS, Seet AM, Gianfrancesco MA, Izadi Z, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Pons-Estel GJ, Isnardi CA, Berbotto GA, Hsu TY, D'Silva KM, Patel NJ, Kearsley-Fleet L, Schäfer M, Ribeiro SLE, Al Emadi S, Tidblad L, Scirè CA, Raffeiner B, Thomas T, Flipo RM, Avouac J, Seror R, Bernardes M, Cunha MM, Hasseli R, Schulze-Koops H, Müller-Ladner U, Specker C, Souza VA, Mota LMHD, Gomides APM, Dieudé P, Nikiphorou E, Kronzer VL, Singh N, Ugarte-Gil MF, Wallace B, Akpabio A, Thomas R, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, et al. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146. PMID: 34049860.
      Citations: 16     Fields:    Translation:Humans
    3. Schulze-Koops H, Krüger K, Hoyer BF, Leipe J, Iking-Konert C, Specker C. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information. Rheumatology (Oxford). 2021 05 14; 60(5):2128-2133. PMID: 33502500.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    4. Richter JG, Chehab G, Knitza J, Krotova A, Schneider M, Voormann AJ, Schulze-Koops H, Specker C. [Annual meeting of the German Society for Rheumatology going virtual-successfully defying the pandemic]. Z Rheumatol. 2021 Jun; 80(5):399-407. PMID: 33877456.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    5. Hasseli R, Pfeil A, Hoyer BF, Krause A, Lorenz HM, Richter JG, Schmeiser T, Voll RE, Schulze-Koops H, Specker C, Müller-Ladner U. Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis? Clin Exp Rheumatol. 2021 May-Jun; 39(3):639-647. PMID: 33822706.
      Citations: 2     Fields:    Translation:Humans
    6. Mühlensiepen F, Kurkowski S, Krusche M, Mucke J, Prill R, Heinze M, Welcker M, Schulze-Koops H, Vuillerme N, Schett G, Knitza J. Digital Health Transition in Rheumatology: A Qualitative Study. Int J Environ Res Public Health. 2021 03 05; 18(5). PMID: 33807952.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    7. Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes I, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19. Ann Rheum Dis. 2021 Feb 05. PMID: 33547062.
      Citations: 11     Fields:    
    8. Iking-Konert C, Specker C, Krüger K, Schulze-Koops H, Aries P. [Current state of vaccination against SARS-CoV-2]. Z Rheumatol. 2021 Mar; 80(2):158-164. PMID: 33528655.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    9. Schulze-Koops H, Specker C, Skapenko A. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines. RMD Open. 2021 02; 7(1). PMID: 33627439.
      Citations: 10     Translation:HumansPHPublic Health
    10. Specker C, Schulze-Koops H. [Vaccination against SARS-CoV-2 in inflammatory rheumatic diseases : Recommendations of the German Society for Rheumatology for physicians and patients]. Z Rheumatol. 2021 02; 80(1):43-44. PMID: 33438061.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    11. Hasseli R, Mueller-Ladner U, Hoyer BF, Krause A, Lorenz HM, Pfeil A, Richter J, Schäfer M, Schmeiser T, Strangfeld A, Schulze-Koops H, Voll RE, Specker C, Regierer AC. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. RMD Open. 2021 01; 7(1). PMID: 33479021.
      Citations: 16     Translation:Humans
    12. Muehlensiepen F, Mucke J, Krusche M, Kurkowski S, Bendzuck G, Koetter I, Lemarié V, Grahammer M, Heinze M, Schulze-Koops H, Knitza J. The virtual fishbowl: bringing back dynamic debates to medical conferences. Ann Rheum Dis. 2021 05; 80(5):675-676. PMID: 33323355.
      Citations: 8     Fields:    Translation:Humans
    13. Schulze-Koops H, Skapenko A, Krause A, Krueger K, Lorenz HM, Sewerin P, Specker C, Wagner UG, Voormann A, Mueller-Ladner U, Voll RE. Correspondence to 'Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases'. Ann Rheum Dis. 2020 Oct 30. PMID: 33127664.
      Citations:    Fields:    
    14. Hasseli R, Mueller-Ladner U, Schmeiser T, Hoyer BF, Krause A, Lorenz HM, Regierer AC, Richter JG, Strangfeld A, Voll RE, Pfeil A, Schulze-Koops H, Specker C. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. RMD Open. 2020 09; 6(2). PMID: 32878994.
      Citations: 19     Translation:HumansCellsPHPublic Health
    15. Schulze-Koops H, Iking-Konert C, Leipe J, Hoyer BF, Holle J, Moosig F, Aries P, Burmester G, Fiehn C, Krause A, Lorenz HM, Schneider M, Sewerin P, Voormann A, Wagner U, Krüger K, Specker C. [Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]. Z Rheumatol. 2020 Sep; 79(7):679-685. PMID: 32757030.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    16. Leipe J, Hoyer BF, Iking-Konert C, Schulze-Koops H, Specker C, Krüger K. [SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments]. Z Rheumatol. 2020 Sep; 79(7):686-691. PMID: 32845393.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    17. Schulze-Koops H, Krueger K, Vallbracht IV, Hasseli R, Skapenko A. Treatment of patients with inflammatory rheumatic diseases with rituximab should be carefully considered during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al' by Benucci et al. Ann Rheum Dis. 2020 Aug 04. PMID: 32753421.
      Citations: 1     Fields:    
    18. Landewé RBM, Schulze-Koops H. Response to: 'Should patients starting biologics be screened for COVID-19?' by Cardenas-de la Garza et al. Ann Rheum Dis. 2020 Jul 22. PMID: 32699038.
      Citations:    Fields:    
    19. Schulze-Koops H, Krueger K, Vallbracht I, Hasseli R, Skapenko A. Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab. Ann Rheum Dis. 2021 05; 80(5):e67. PMID: 32591357.
      Citations: 30     Fields:    Translation:Humans
    20. Schulze-Koops H, Specker C, Krueger K. Telemedicine holds many promises but needs to be developed to be accepted by patients as an alternative to a visit to the doctor. Response to: 'Patient acceptance of using telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak' by So et al. Ann Rheum Dis. 2020 Jun 24. PMID: 32581084.
      Citations: 5     Fields:    
    21. Schulze-Koops H, Krueger K, Specker C. Actions required to assure continuous supply of anti-rheumatic medication during the SARS-CoV-2/COVID-19 pandemic. Response to: 'Treatment adherence behaviours in rheumatic diseases during pandemic COVID-19: a Latin American experience' by Pineda-Sic et al. Ann Rheum Dis. 2020 Jun 23. PMID: 32576567.
      Citations:    Fields:    
    22. Landewé RB, Machado PM, Kroon F, Bijlsma HW, Burmester GR, Carmona L, Combe B, Galli M, Gossec L, Iagnocco A, Isaacs JD, Mariette X, McInnes I, Mueller-Ladner U, Openshaw P, Smolen JS, Stamm TA, Wiek D, Schulze-Koops H. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis. 2020 07; 79(7):851-858. PMID: 32503854.
      Citations: 66     Fields:    Translation:HumansCellsPHPublic Health
    23. Schulze-Koops H, Krueger K, Specker C. No advice to discontinue antirheumatic therapy for non-medical reasons in light of SARS-CoV-2. Response to: 'Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic' by Fragoulis et al. Ann Rheum Dis. 2020 May 31. PMID: 32475833.
      Citations: 1     Fields:    
    24. Schulze-Koops H, Holle J, Moosig F, Specker C, Aries P, Burmester G, Fiehn C, Hoyer B, Krause A, Leipe J, Lorenz HM, Schneider M, Sewerin P, Voormann A, Wager U, Krüger K, Iking-Konert C. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic]. Z Rheumatol. 2020 May; 79(4):385-388. PMID: 32342184.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    25. Schulze-Koops H, Specker C, Iking-Konert C, Holle J, Moosig F, Krueger K. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic. Ann Rheum Dis. 2020 06; 79(6):840-842. PMID: 32345619.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    Schulze-Koops's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (217)
    Explore
    _
    Co-Authors (158)
    Explore
    _
    Similar People (60)
    Explore
    _